Optimisation of inhaled tuberculosis therapies and implications for host-pathogen interactions

Tuberculosis

Volumn 91, Issue 1, 2011, Pages 64-

  Hickey, Anthony J ^a   Misra, Amit ^b   Robertson, Brian D ^c  

^a University of North Carolina   (United States)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TOBRAMYCIN; TUBERCULOSTATIC AGENT;

EDITORIAL; HOST PATHOGEN INTERACTION; HUMAN; PRIORITY JOURNAL; PSEUDOMONAS INFECTION; TUBERCULOSIS;

ADMINISTRATION, INHALATION; ANTITUBERCULAR AGENTS; HOST-PATHOGEN INTERACTIONS; HUMANS; TUBERCULOSIS;

EID: 79551474871     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2010.10.002     Document Type: Editorial

References (0)